CIPN is one of the most common lasting effects of cancer treatment, and one of the least addressed after treatment ends.
Which agents are associated
Platinum compounds, taxanes, vinca alkaloids, bortezomib, and thalidomide are the classes most commonly implicated. Risk relates to agent, cumulative dose, and individual factors including pre-existing neuropathy, diabetes, and nutritional status.
How it typically presents
Symmetric symptoms beginning in the toes and fingertips and progressing proximally. Numbness, tingling, burning. Loss of fine motor precision — buttons, jewelry clasps, keys. Balance changes. Cold sensitivity is characteristic of certain platinum agents.
Symptoms sometimes worsen for a period after treatment ends before stabilizing.
The course over time
Some CIPN resolves. Some improves partially. Some persists indefinitely. Which of those applies depends on the agent, the cumulative dose, and how much nerve was affected.
We will not tell you which one you are before evaluating you, and we would be skeptical of anyone who does.
Why evaluation still matters after treatment
Two reasons.
First, CIPN often layers on top of something else. Undiagnosed prediabetes, B12 depletion from treatment or medication, thyroid changes, or nutritional deficits from a difficult treatment period can all compound chemotherapy’s effect. Those contributors are modifiable even when the chemotherapy exposure is not.
Second, not everything that develops after cancer treatment is CIPN. Establishing the cause of symptoms is not the same as assuming it.
On coordination
We work alongside your oncology team, not instead of it. Anything relevant to your cancer care goes back to them.
Free 15-minute phone consultation.
FAQ
How long does chemotherapy neuropathy last?
Highly variable. Some resolves within months, some improves partially over one to two years, and some is permanent. Agent, cumulative dose, and severity at onset are the main predictors.
Can anything help CIPN after treatment ends?
Evaluation is worthwhile because compounding contributors — nutritional, metabolic, endocrine — are common and are modifiable independent of the chemotherapy exposure itself.
Reviewed by Alvin Philipose, DC, ICCP. This page is for informational purposes only and does not constitute medical advice. Individual results vary and no outcome is guaranteed. If you are experiencing sudden weakness, difficulty breathing or swallowing, new bowel or bladder changes, or a wound or infection on your foot, seek emergency care.